- Caporuscio, C., & Fink, S. B. (2024). Epistemic Risk Reduction in Psychedelic-Assisted Therapy. Current topics in behavioral neurosciences, 10.1007/7854_2024_531. Advance online publication. https://doi.org/10.1007/7854_2024_531
- Caporuscio, C., & Kind, A. (2024). Therapist, Trip Sitter Or Guide? A Second-Person Perspective on Psychedelic-Assisted Psychotherapy. In The Palgrave Handbook of Philosophy and Psychoactive Drug Use (pp. 513-530). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-65790-0_25
- Repantis, D., Koslowski, M., & Fink, S. B. (2024). Ethische Aspekte der Therapie mit Psychedelika. Die Psychotherapie, 1-7.
- C. Bublitz & L. Böllinger (2024), Substanz und Modalität. Rechtliche Fragen der Regulierung psychedelischassistierter Therapien. Nervenheilkunde 5/2024, 275-283.
- Langlitz, N., Gearin, A.K. (2024). Psychedelic Therapy as Form of Life. Neuroethics 17, 14. https://doi.org/10.1007/s12152-024-09550-9
- Bublitz, Christoph (2024), Zur strafrechtlichen Lage von Therapien mit Psychedelika. Medizinrecht 42: 26–32. http://10.1007/s00350-023-6649-8
- Langlitz, Nicolas (2023), “The Making of a Mushroom People: Toward a Moral Anthropology of Psychedelics beyond Hype and Anti‐hype.” Anthropology Today 39, no. 3 (June 2023): 10–12. https://doi.org/10.1111/1467-8322.12813.
- Bublitz, Christoph, Nicolas Langlitz, and Dimitris Repantis (2023). “Control Side Effects of the Psychedelic Renaissance.” Nature 620, no. 7973 (August 10, 2023): 277–277. https://doi.org/10.1038/d41586-023-02495-8
- Bublitz, Christoph (2023). “What an International Declaration on Neurotechnologies and Human Rights Could Look like: Ideas, Suggestions, Desiderata.” AJOB Neuroscience (November 3, 2023): 1–17. https://doi.org/10.1080/21507740.2023.2270512.